Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Investing

Eli Lilly : LLY

All Eli Lilly Articles

624 Articles

Lee Jackson | Feb 27, 2026 at 8:11 AM EST

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return. Total…

Lee Jackson | Feb 25, 2026 at 7:57 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” …

David Beren | Feb 25, 2026 at 7:08 AM EST

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

After finding itself some unwanted attention this week, Novo Nordisk (NYSE:NVO | NVO Price Prediction) has dropped 22% in the…

David Beren | Feb 16, 2026 at 2:00 PM EST

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

Editor’s note: A prior version of this article stated Eli Lilly and Nvidia had funded a supercomputer, when the commitment…

Joey Frenette | Feb 12, 2026 at 10:00 AM EST

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s…

Joel South | Feb 12, 2026 at 8:20 AM EST

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

24/7 Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue…

John Seetoo | Feb 11, 2026 at 7:15 AM EST

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

One of the biggest trends in the fight against obesity has been the explosion in popularity of GLP-1 medications. Created…

Rich Duprey | Feb 4, 2026 at 2:39 PM EST

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

The rivalry in the GLP-1 market between pharmaceutical leaders Eli Lilly (NYSE:LLY | LLY Price Prediction) and Novo Nordisk (NYSE:NVO)…

Joel South | Feb 2, 2026 at 11:40 AM EST

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open. Wall Street expects earnings of…

Michael Williams | Jan 23, 2026 at 2:06 PM EST

Investor Bets $100k On David v Goliath Matchup With Altimmune and Eli Lilly

Shares of Altimmune (NASDAQ:ALT) surged 35.4% over the past week, coinciding with a dramatic shift in retail investor sentiment on…

Austin Smith | Jan 23, 2026 at 10:36 AM EST

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss drug revolution.…

Joey Frenette | Jan 22, 2026 at 1:17 PM EST

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7

It feels like a great rotation out of the Magnificent Seven has already kicked off just over a quarter ago.…

Trey Thoelcke | Jan 19, 2026 at 8:45 AM EST

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Alumis, Aktis Oncology, and W.R. Berkley saw the most prominent insider buying of the past week. There were a handful…

Rich Duprey | Jan 12, 2026 at 12:48 PM EST

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process…

William Temple | Jan 10, 2026 at 8:59 AM EST

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but…

1 2 3 4 5 … 42

Eli Lilly : LLY

All Eli Lilly Articles

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Investor Bets $100k On David v Goliath Matchup With Altimmune and Eli Lilly

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Live Nasdaq Composite: Bulls Keep Control on Tech Deals, Chip Profit Growth and Easing Oil

AIRR, PAVE, and XLI: Which Reshoring ETF Wins as Factories Return Home

Shopify Eyes 7% Upside After Brutal 2026 Selloff

Oklo Advances 12% on NRC Aurora Approval: Is This the AI Infrastructure Nuclear Play?

How to Build $2,000 a Month in Dividend Income

Working Past 70 Does Not Grow Your Social Security Check -- Or Does It?

AIRR, PAVE, and XLI: Which Reshoring ETF Wins as Factories Return Home

Shopify Eyes 7% Upside After Brutal 2026 Selloff

Eli Lilly : LLY

All Eli Lilly Articles

5 US Blue Chip Giants That Have Paid Dividends for Over 100 Years

Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Investor Bets $100k On David v Goliath Matchup With Altimmune and Eli Lilly

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma’s Future

The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth

Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Live Nasdaq Composite: Bulls Keep Control on Tech Deals, Chip Profit Growth and Easing Oil

AIRR, PAVE, and XLI: Which Reshoring ETF Wins as Factories Return Home

Shopify Eyes 7% Upside After Brutal 2026 Selloff

Oklo Advances 12% on NRC Aurora Approval: Is This the AI Infrastructure Nuclear Play?

Featured Reads

How to Build $2,000 a Month in Dividend Income

Working Past 70 Does Not Grow Your Social Security Check -- Or Does It?